
Bernard Escudier, MD, Institut Gustave Roussy
Advertisement
Articles by Bernard Escudier, MD, Institut Gustave Roussy










Advertisement
Latest Updated Articles
Role of TKI After Progression on I/O for mRCCPublished: October 23rd 2020 | Updated:
Emerging Agents for Progressive mRCCPublished: October 23rd 2020 | Updated:
Review of the COSMIC 021 Study for mRCCPublished: October 23rd 2020 | Updated:
I/O Therapy After Progression on I/O for mRCCPublished: October 23rd 2020 | Updated:
Introduction and Review of CheckMate 9ER for Metastatic RCCPublished: October 23rd 2020 | Updated:
Clinical Trials for Relapsed/Refractory mRCCPublished: October 23rd 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
2
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
3
PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous Ovarian Cancer
4
FDA Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma
5

